Fibrinogen Is a Predictor of Mortality in Coronary Heart Disease Patients
Open accessAbstract
Abstract Results of epidemiological studies have indicated that fibrinogen is an important primary cardiovascular risk factor. The role of fibrinogen as a predictor of mortality in coronary heart disease (CHD) patients is unclear. We investigated the association between fibrinogen and mortality in a large cohort of CHD patients screened for participation in a secondary prevention clinical trial. Of the total investigated, 3092 men who were not included in the trial and for whom vital status was known were followed up for a mean period of 3.2 years. In 54.4% of the 111 men who died, mortality was attributed to CHD. Mean baseline plasma fibrinogen levels were 29.4 mg/dL higher in patients who died than in the survivors. All-cause and CHD mortality rates increased with increasing fibrinogen levels. This relationship was also demonstrated within categories of the primary variables predicting mortality in these patients. The contribution of fibrinogen to CHD and all-cause mortality was assessed by multivariate analysis adjusting for age, CHD severity, and comorbidity. Risks of CHD and all-cause mortality for patients in the highest fibrinogen tertile were 1.67 and 1.75, respectively, relative to patients in the lowest tertile, and an increase of about 1 SD of plasma fibrinogen level (75 mg/dL) was found to increase risk of CHD and all-cause mortality by 29% and 31%, respectively. These results indicate clearly that fibrinogen level is associated with significantly increased mortality in CHD patients. Implementation of a standardized measuring method is required to allow assessment of risk in CHD patients on the basis of fibrinogen levels.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the BIP Study, fibrinogen was shown to be a predictor of mortality.
“In the BIP Study, a large-scale clinical study on bezafibrate, fibrinogen was shown to be a predictor of mortality [113]”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [113]
Fibrinogen is an excellent predictor of mortality especially in patients with cardiovascular complications.
“Fibrinogen is an excellent predictor of mortality especially in patients with cardiovascular complications [11, 12].”
From GHK and DNA: Resetting the human genome to health (2014) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937 · see citing works
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645 · see citing works
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387 · see citing works
Fibrinogen as a Cardiovascular Risk Factor
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 998 · see citing works
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915 · see citing works
Fibrinogen and Risk of Cardiovascular Disease
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 894 · see citing works
HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY
Meade, T. W., Chakrabarti, R., Haines, A., North, W. R. S., Stirling, Y., Thompson, S. G., & Brozović, M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91498-1 · Cited by 691 · see citing works
Heinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563 · see citing works
Influence of platelet size on outcome after myocardial infarction
Martin, J. F., Bath, P. M., & Burr, M. L. (1991) · The Lancet · doi:10.1016/0140-6736(91)92719-i · Cited by 494 · see citing works
Ridker, P. M., Hennekens, C. H., Cerskus, A. L., & Stampfer, M. J. (1994) · Circulation · doi:10.1161/01.cir.90.5.2236 · Cited by 243 · see citing works
Fowkes, F. G. R., Housley, E., Rattray, A., Lowe, G. D. O., Rumley, A., Elton, R. A., MacGREGOR, I. R., & Dawes, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91288-w · Cited by 191 · see citing works
Lee, A. J., Lowe, G. D. O., Woodward, M., & Tunstall‐Pedoe, H. (1993) · Heart · doi:10.1136/hrt.69.4.338 · Cited by 164 · see citing works
Goldbourt, U., Behar, S., Reicher-Reiss, H., Agmon, J., Kaplinsky, E., Graft, E., Kishon, Y., Caspi, A., Weisbort, J., Mandelzweig, L., et al. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90905-r · Cited by 153 · see citing works
Self-citationBanerjee, A. K., Pearson, J., Gilliland, E. L., Goss, D. E., Lewis, J. D., Stirling, Y., & Meade, T. W. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656361 · Cited by 109 · see citing works
Barasch, E., Benderly, M., Graff, E., Behar, S., Reicher-Reiss, H., Caspi, A., Pelled, B., Reisin, L., Roguin, N., & Goldbourt, U. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00191-r · Cited by 51 · see citing works
Self-citationKinetic Aspects of the Interaction of Blood Clotting Enzymes
Hemker, H. C., Kop, J. M. M., & Willems, G. M. (1979) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646650 · Cited by 21 · see citing works
A SAS program for evaluating person-years of risk in cohort studies
Yaari, S., & Goldbourt, U. (1989) · Computers in Biology and Medicine · doi:10.1016/0010-4825(89)90056-5 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- Stone MC, Thorp J. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985;35:564-569.
- Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation. 1991;83:836-844.
- SASISTAT User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute Inc; 1987; 1:943 and 1987;2:620.
- Cary, NC: SAS Institute Inc; 1992:620. SAS technical report P-229.
- Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Study. J Clin Epidemiol. 1990;16:83-88.
Cited by
Sorted by citations
Danesh, J., Collins, R., Appleby, P. N., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,027 · see citing works
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,120 · see citing works
Self-citationIncreased plasma viscosity during an air pollution episode: a link to mortality?
Peters, A., Döring, A., Wichmann, H.-E., & Koenig, W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01211-7 · Cited by 706 · see citing works
Toss, H., Lindahl, B., Siegbahn, A., Wallentin, L. C., & for the FRISC Study Group (1997) · Circulation · doi:10.1161/01.cir.96.12.4204 · Cited by 519 · see citing works
Circulating markers of inflammation and atherosclerosis
Lind, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00012-1 · Cited by 369 · see citing works
Balagopal, P., de Ferranti, S. D., Cook, S., Daniels, S. R., Gidding, S. S., Hayman, L. L., McCrindle, B. W., Mietus‐Snyder, M., & Steinberger, J. (2011) · Circulation · doi:10.1161/cir.0b013e31821c7c64 · Cited by 353 · see citing works
Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke
Napoli, M. D., Papa, F., & Bocola, V. (2001) · Stroke · doi:10.1161/01.str.32.1.133 · Cited by 317 · see citing works
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction
Maresca, G., Blasio, A. D., Marchioli, R., & Minno, G. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.6.1368 · Cited by 305 · see citing works
Vlachopoulos, C., Aznaouridis, K. A., Ioakeimidis, N., Rokkas, K., Vasiliadou, C., Alexopoulos, N. A., Stefanadi, E., Askitis, A., & Stefanadis, C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl341 · Cited by 236 · see citing works
Yamashita, S., Masuda, D., & Matsuzawa, Y. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-0823-5 · Cited by 191 · see citing works
Klempfner, R., Erez, A., Sagit, B.-Z., Goldenberg, I., Fisman, E., Kopel, E., Shlomo, N., Israel, A., & Tenenbaum, A. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002104 · Cited by 180 · see citing works
Fibrates, dyslipoproteinaemia and cardiovascular disease
Watts, G. F., & Dimmitt, S. B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00011 · Cited by 145 · see citing works
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
Wang, L., Cai, Y., Jian, L., Cheung, C. W., Zhang, L., & Xia, Z. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01188-0 · Cited by 114 · see citing works
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
Bickerton, A. S. T., Clark, N. M., Meeking, D. R., Shaw, K. M., Crook, M. A., Lumb, P. J., Turner, C., & Cummings, M. H. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015271 · Cited by 109 · see citing works
Tenenbaum, A., & Fisman, E. Z. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-140 · Cited by 108 · see citing works
Coronary atherogenic risk factors in women.
Stangl, V., Baumann, G., & Stangl, K. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3329 · Cited by 124 · see citing works
Tommasi, S., Carluccio, E., Bentivoglio, M., Buccolieri, M., Mariotti, M., Politano, M., & Corea, L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00162-9 · Cited by 104 · see citing works
Fisman, E. Z., Tenenbaum, A., Adler, Y., Motro, M., Boyko, V., Benderly, M., FRIEDENSOHN, A., Kohanovski, M., Rotzak, R., Schneider, H., et al. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240210 · Cited by 104 · see citing works
Self-citationHaim, M., Tanné, D., Boyko, V., Reshef, T., Goldbourt, U., Leor, J., Mekori, Y. A., & Behar, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01728-x · Cited by 102 · see citing works
Self-citationHaemostatic factors and prediction of ischaemic heart disease and stroke in claudicants
Smith, Rumley, Lee, Leng, Fowkes, & Lowe (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00626.x · Cited by 100 · see citing works
Спивак, Б., Vered, Y., Yoran‐Hegesh, R., Averbuch, E., Mester, R., Graf, E., & Weizman, A. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb07229.x · Cited by 99 · see citing works
Fibrinogen and Cardiovascular Risk
Ernst, E., & Köenig, W. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200207 · Cited by 99 · see citing works
Fröhlich, M., Sund, M., Russ, S., Hoffmeister, A., Fischer, H.-G., Hombach, V., & Köenig, W. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2692 · Cited by 98 · see citing works
Fisman, E. Z., Motro, M., Tenenbaum, A., Boyko, V., Mandelzweig, L., & Behar, S. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113219 · Cited by 95 · see citing works
Self-citationExercise intervention and inflammatory markers in coronary artery disease: A meta-analysis
Swardfager, W., Herrmann, N., Cornish, S., Mazereeuw, G., Marzolini, S., Sham, L., & Lanctôt, K. L. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.12.017 · Cited by 91 · see citing works
der Velden, M. G. M. D. S., Kaysen, G. A., de Meer, K., Stellaard, F., Voorbij, H. A. M., Reijngoud, D., Rabelink, T. J., & Koomans, H. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00729.x · Cited by 87 · see citing works
Utility of inflammatory markers in the management of coronary artery disease
Rosenson, R. S., & Köenig, W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00504-6 · Cited by 85 · see citing works
Papadakis, J. A. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00049-7 · Cited by 81 · see citing works
Smith, G. D., Rumley, A., Lowe, G. D. O., Ebrahim, S. B. J., & Lawlor, D. A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0805 · Cited by 72 · see citing works
Cardiovascular disease and chronic kidney disease: Insights and an update
Best, P. J. M., Reddan, D. N., Berger, P. B., Szczech, L. A. M., McCullough, P. A., & Califf, R. M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.011 · Cited by 70 · see citing works
Yamashita, S., Masuda, D., & Matsuzawa, Y. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48918 · Cited by 68 · see citing works
Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke
Turaj, W., Słowik, A., Dziedzic, T., Pułyk, R., Adamski, M. G., Strojny, J., & Szczudlik, A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.01.020 · Cited by 66 · see citing works
Haim, M., Boyko, V., Goldbourt, U., Battler, A., & Behar, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.4.433 · Cited by 65 · see citing works
Self-citationRelationship Between Plasma Fibrinogen and Coronary Heart Disease in Women
Eriksson, M., Egberg, N., Wamala, S. P., Orth‐Gomér, K., Mittleman, M. A., & Schenck-Gustafsson, K. G. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.67 · Cited by 61 · see citing works
Shamsuzzaman, A., Amin, R. S., Calvin, A. D., Davison, D. E., & Somers, V. K. (2014) · Sleep And Breathing · doi:10.1007/s11325-014-0938-4 · Cited by 57 · see citing works
Shimbo, D., Davidson, K. W., Haas, D. C., Fuster, V., & Badimón, J. J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01084.x · Cited by 56 · see citing works
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease
Fibrinogen Studies Collaboration∗ (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000114968.39211.01 · Cited by 56 · see citing works
Routledge, H., & Ayres, J. G. (2005) · Occupational Medicine · doi:10.1093/occmed/kqi136 · Cited by 54 · see citing works
Goa, K. L., Barradell, L. B., & Plosker, G. L. (1996) · Drugs · doi:10.2165/00003495-199652050-00008 · Cited by 54 · see citing works
Hemingway, H., Henriksson, M., Chen, R., Damant, J., Fitzpatrick, N. K., Abrams, K. R., Hingorani, A. D., Janzon, M., Shipley, M. J., Feder, G. S., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14090 · Cited by 51 · see citing works
Breddin, H. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00056-8 · Cited by 51 · see citing works
Tanné, D., Benderly, M., Goldbourt, U., Boyko, V., Brunner, D., Graff, E., Reicher-Reiss, H., Shotan, A., Mandelzweig, L., & Behar, S. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00914-7 · Cited by 51 · see citing works
Self-citationSmith, F. B. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2127 · Cited by 49 · see citing works
Ziakas, A., Gavrilidis, S., Giannoglou, G. D., Souliou, E., Gemitzis, K., Kalampalika, D., Vayona, M. A., Pidonia, I., Parharidis, G., & Louridas, G. E. (2006) · Angiology · doi:10.1177/000331970605700304 · Cited by 48 · see citing works
Chesney, C. M., Elam, M. B., Herd, J. A., Davis, K. B., Garg, R., Hunninghake, D. B., Kennedy, J. W., & Applegate, W. B. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109648 · Cited by 48 · see citing works
Progressive intermittent claudication is associated with impaired fibrinolysis
Killewich, L. A., Gardner, A. W., Macko, R. F., Hanna, D. J., Goldberg, A. P., Cox, D. K., & Flinn, W. R. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70229-0 · Cited by 46 · see citing works
Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism
Martinez, M. R., Cuker, A. C., Mills, A. M., Lightfoot, R. T., Fan, Y., Tang, W. H. W., Hazen, S. L., & Ischiropoulos, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.004 · Cited by 44 · see citing works
Köenig, W., Sund, M., Löwel, H., Döring, A., & Ernst, E. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02026.x · Cited by 42 · see citing works
Fibrinogen and Preclinical Echocardiographic Target Organ Damage
Palmieri, V., Celentano, A., Roman, M. J., SIMONE, G. D., Lewis, M. R., Best, L. G., Lee, E. T., Robbins, D. C., Howard, B. V., & Devereux, R. B. (2001) · Hypertension · doi:10.1161/hy1101.095335 · Cited by 40 · see citing works
GHK and DNA: Resetting the human genome to health
Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2014) · BioMed Research International · doi:10.1155/2014/151479 · Cited by 39 · see citing works
Yamashita, S., Rizzo, M., Su, T., & Masuda, D. (2023) · Metabolites · doi:10.3390/metabo13050626 · Cited by 40 · see citing works
Fisman, E. Z., Motro, M., Tenenbaum, A., Leor, J., Boyko, V., Mandelzweig, L., Sherer, Y., Adler, Y., & Behar, S. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000124326.85096.ec · Cited by 36 · see citing works
Self-citationThrombus Precursor Protein and Clinical Outcomes in Patients With Acute Coronary Syndromes
Mega, J. L., Morrow, D. A., de Lemos, J. A., Mohanavelu, S., Cannon, C. P., & Sabatine, M. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.069 · Cited by 32 · see citing works
Independent Association of Fibrinogen with Carotid Intima-Media Thickness in Asymptomatic Subjects
Martínez‐Vila, E., Páramo, J. A., Beloqui, Ó., Orbe, J., Irimia, P., Colina, I., Monreal, I., Benito, A., Barba, J., Zubieta, J. L., et al. (2003) · Cerebrovascular Diseases · doi:10.1159/000072557 · Cited by 32 · see citing works
Tenenbaum, A., Motro, M., Fisman, E. Z., Boyko, V., Mandelzweig, L., Reicher-Reiss, H., Graff, E., Brunner, D., & Behar, S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01244-3 · Cited by 32 · see citing works
Self-citationFibrinogen: Associations with cardiovascular events in an outpatient clinic
Mónica Acevedo, B., Foody, J. M., Pearce, G. L., & Sprecher, D. L. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119766 · Cited by 31 · see citing works
Patho- physiological role of BDNF in fibrin clotting
Amadio, P., Porro, B., Sandrini, L., Fiorelli, S., Bonomi, A., Cavalca, V., Brambilla, M., Camera, M., Veglia, F., Tremoli, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37117-1 · Cited by 29 · see citing works
Sutter, J. D. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00703-6 · Cited by 28 · see citing works
Camilleri, R. S., Peebles, D., Portmann, C. S., Everington, T., & Cohen, H. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200403000-00005 · Cited by 27 · see citing works
Ganotakis, E. S., Vrentzos, G. E., Gazi, I. F., Papadakis, J. A., Jagroop, A. I., Paraskevas, K. I., Nair, D. R., & Mikhailidis, D. P. (2007) · PubMed · Cited by 26 · see citing works
Vorster, H. H. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00033-x · Cited by 26 · see citing works
Metabolic risk factors for coronary heart disease: current and future prospects
Wilson, P. W. F. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199903000-00016 · Cited by 25 · see citing works
Byrne, C. E., Fitzgerald, A. J., Cannon, C. P., Fitzgerald, D. J., & Shields, D. C. (2004) · BMC Medical Genetics · doi:10.1186/1471-2350-5-13 · Cited by 24 · see citing works
Pieters, M., Ferreira, M., de Maat, M. P. M., & Ricci, C. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.009 · Cited by 23 · see citing works
Park, C. T., & Wright, S. D. (2000) · Blood · doi:10.1182/blood.v95.1.198 · Cited by 23 · see citing works
Concordant Message of Different Inflammatory Markers in Patients with Rheumatoid Arthritis
Arvidsson, N. G., Guðbjörnsson, B., Hällgren, R., & Larsson, A. O. (1998) · Upsala Journal of Medical Sciences · doi:10.3109/03009739809178943 · Cited by 22 · see citing works
Tenenbaum, A., Fisman, E. Z., Boyko, V., Goldbourt, U., Auerbach, I., Shemesh, J., Shotan, A., Reicher-Reiss, H., Behar, S., & Motro, M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00279-9 · Cited by 22 · see citing works
Self-citationRedondo, M., Carroll, V. A., Mauron, T., Biasiutti, F. D., Binder, B. R., Lämmle, B., & Wuillemin, W. A. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200101000-00003 · Cited by 20 · see citing works
Carlson, C. S., Heagerty, P. J., Nord, A. S., Pritchard, D. K., Ranchalis, J., Boguch, J. M., Duan, H., Hatsukami, T. S., Schwartz, S. M., Rieder, M. J., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0289-8 · Cited by 20 · see citing works
Is clopidogrel markedly superior to aspirin in patients with peripheral vascular disease?
Mikhailidis, D. P. (1998) · Platelets · doi:10.1080/09537109876492 · Cited by 20 · see citing works
Evaluation of Oxidative Stress and hsCRP in Polycystic Ovarian Syndrome in a Tertiary Care Hospital
Sumithra, N., Lakshmi, R., Menon, N. L., Subhakumari, K. N., & Sheejamol, V. S. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0427-3 · Cited by 19 · see citing works
Papadakis, J. A., Mikhailidis, D. P., Vrentzos, G. E., Kalikaki, A., Kazakou, I. M., & Ganotakis, E. S. (2005) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960501100203 · Cited by 19 · see citing works
Hypertension in Diet Versus Pharmacologically Treated Diabetics
Tenenbaum, A., Fisman, E. Z., Boyko, V., Goldbourt, U., Graff, E., Shemesh, J., Shotan, A., Reicher-Reiss, H., Behar, S., & Motro, M. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.1002 · Cited by 19 · see citing works
Self-citationPiantella, S., Dragano, N., Marques, M. D., McDonald, S. J., & Wright, B. J. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110657 · Cited by 17 · see citing works
Brown, J. C., Harhay, M. O., & Harhay, M. N. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1308-8 · Cited by 17 · see citing works
Haim, M., Tanné, D., Goldbourt, U., Doolman, R., Boyko, V., Brunner, D., Sela, B., & Behar, S. (2006) · Cardiology · doi:10.1159/000093697 · Cited by 17 · see citing works
Self-citationRetterstøl, L., Kierulf, P., Pedersen, J. C., Bohn, M., Bakken, A., Erikssen, J., & Berg, K. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00837.x · Cited by 17 · see citing works
Raja, B., Kaviarasan, K., Arjunan, M. M., & Pugalendi, K. V. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.5373 · Cited by 16 · see citing works
New circulating biomarkers for predicting cardiovascular death in healthy population
Melander, O., Modrego, J., Zamorano‐León, J. J., Santos-Sancho, J. M., Lahera, V., & López-Farré, A. J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12652 · Cited by 16 · see citing works
BARCLAY, J. L., Hillis, G. S., & Ayres, J. G. (2005) · Toxicological Reviews · doi:10.2165/00139709-200524020-00005 · Cited by 16 · see citing works
Fibrinogen und Atherothrombose: vulnerable Plaque oder vulnerabler Patient?
Jaeger, B. R., & Labarrere, C. A. (2003) · Herz · doi:10.1007/s00059-003-2497-5 · Cited by 16 · see citing works
Do lipid lowering drugs reduce the risk of coronary heart disease?
Pritzker, L. (1998) · Critical reviews in clinical laboratory sciences · doi:10.1080/10408369891234291 · Cited by 16 · see citing works
Fibrinogen and mortality in chronic critical limb ischaemia
Pedrinelli, R., Omo, G. D., Barchielli, A., Berchiolli, R. N., Melillo, E., Mariani, M., Balbarini, A., & Ferrari, M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00410.x · Cited by 15 · see citing works
Stormorken, H., & Sakaríassen, K. S. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00157-6 · Cited by 15 · see citing works
Tenenbaum, A., Motro, M., Fisman, E. Z., Leor, J., Boyko, V., Mandelzweig, L., & Behar, S. (2003) · Cardiology · doi:10.1159/000074814 · Cited by 14 · see citing works
Self-citationControl of Fibrinogen Biosynthesis: Role of the FFA/Albumin Ratio
Pilgeram, L. O. (2010) · Cardiovascular Engineering An International Journal · doi:10.1007/s10558-010-9092-1 · Cited by 14 · see citing works
Variability in fibrinogen measurements: an obstacle to cardiovascular risk stratification
Rosenson, R. S., Mosca, L. J., Staffileno, B. A., & Tangney, C. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00503-2 · Cited by 14 · see citing works
Muggenburg, L. T. B. A. (2000) · Inhalation Toxicology · doi:10.1080/08958370050123225 · Cited by 13 · see citing works
Le fibrinogène a-t-il une place pour évaluer le risque d’accident cardiovasculaire ischémique ?
Drouet, L. O., & Sollier, C. B. D. (2005) · Therapies · doi:10.2515/therapie:2005017 · Cited by 12 · see citing works
Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients
Culleton, B. F., & Wilson, P. W. F. (1999) · Seminars in Dialysis · doi:10.1046/j.1525-139x.1999.00002.x · Cited by 12 · see citing works
Otto, Parhofer, Ritter, Richter, & Schwandt (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00816.x · Cited by 11 · see citing works
Ganotakis, E. S., Gazi, I. F., Papadakis, J. A., Jagroop, I. A., Nair, D. R., & Mikhailidis, D. P. (2007) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029606296256 · Cited by 11 · see citing works
A COMPARATIVE STUDY OF PLASMA FIBRINOGEN AMONG HOOKAH SMOKERS, CIGARETTE SMOKERS AND NON-SMOKERS
Sezavar, S. H., Abedi, A. R., & Bazargani, H. S. (2004) · Cited by 10 · see citing works
Impaired Fibrinolytic Activity Is Present in Children with Dyslipidemias
Albisetti, M., Chan, A. K. C., McCrindle, B. W., Wong, D., Monagle, P., & Andrew, M. E. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000112098.64368.8a · Cited by 10 · see citing works
Canseco‐Ávila, L. M., López-Roblero, A., Serrano‐Guzmán, E., Aguilar‐Fuentes, J., Carlos Jerjes-Sánchez, D., Rojas‐Martínez, A., & Ortı́z-López, R. (2019) · Disease Markers · doi:10.1155/2019/5769514 · Cited by 9 · see citing works
Páramo, J. A., Rodríguez, J. A., & Orbe, J. (2005) · Medicina Clínica · doi:10.1157/13075852 · Cited by 9 · see citing works
Camilleri, R. S., & Cohen, H. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000164428.13417.e2 · Cited by 8 · see citing works
Interaction of physical activity and diet: implications for haemostatic factors
Rauramaa, R., & Väisänen, S. (1999) · Public Health Nutrition · doi:10.1017/s136898009900052x · Cited by 8 · see citing works
Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese
Liu, Y. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.e31 · Cited by 7 · see citing works
Meco, J. F., Vila-Coll, R., Pujol, R., Bros, R., Domènech, P., Fiol, C., & Pintó, X. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200108000-00011 · Cited by 7 · see citing works
- Authors
- Benderly, M., Graff, E., Reicher-Reiss, H., Behar, S., Brunner, D., & Goldbourt, U.
- Affiliations
- Sheba Medical Center (IL)
- ORCID
- Benderly, Michal
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1996-03
- Volume
- 16
- Issue
- 3
- Pages
- 351-356
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2143889573
- Cited by
- 118
- References
- 18
- Citations by year
- 2023: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 4
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Blood properties and coagulation
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- fibrinogen, coronary artery disease, mortality prediction, cardiovascular risk factors, all-cause mortality, secondary prevention, plasma fibrinogen levels, risk stratification
- MeSH terms
- Aged, Coronary Disease, Fibrinogen, Follow-Up Studies, Humans, Male, Middle Aged, Smoking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
